<DOC>
	<DOCNO>NCT01719172</DOCNO>
	<brief_summary>The objective study determine safety Veriset™ Hemostatic Patch use non-emergent , open , soft tissue surgery topical hemostatic agent would use .</brief_summary>
	<brief_title>A Prospective , Multi-Center , Single-Arm Study Veriset™ Hemostatic Patch Controlling Bleeding Soft Tissue</brief_title>
	<detailed_description />
	<mesh_term>Hemostatics</mesh_term>
	<criteria>Subject authorize representative provide informed consent . Subject ≥ 18 year old . Subject schedule nonemergent surgery topical hemostatic agent would use control bleed emanate tissue bed follow organ dissection removal bleed tumor tissue bed follow resection dissection , via open approach . Subject willing able comply aspect treatment evaluation schedule . Subject appropriate Target Bleeding Site ( TBS ) surgical procedure . TBS bleed assessment Type 2 3 ( refer table protocol ) . Subject pregnant ( documented positive pregnancy test ) actively breastfeed . Subject estimate life expectancy le 6 month . Subject schedule another plan surgery subsequent surgery would jeopardize previous application study treatment . Subject undergoing emergency surgery , i.e . lifesaving procedure perform patient imminent danger death . Subject participate investigational drug device research study within 30 day enrollment would interfere study . Subject active local infection TBS . The investigator determine participation study may jeopardize teh safety welfare subject .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>